NeoPharm Co (092730.KQ) Stock Price
NeoPharm Co Price
Revenue has compounded at 13.7% per year over the past 19 years to 132.18 B KRW. Earnings per share have grown at 6.0% per year over the last 19 years. NeoPharm Co's net margin stands at 21.0%, broadly stable from 20.1% several years earlier. NeoPharm Co currently offers a dividend yield of about 3.26%. The payout ratio is around 42% of earnings. The dividend has grown at 13.5% per year over the past 18 years. Analysts set a median price target of 24,480.00 KRW, implying 6.4% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
NeoPharm Co stock price
NeoPharm Co business model & stock analysis
Frequently asked questions about NeoPharm Co
Analysts currently set an average price target of 24,480.00 KRW for the NeoPharm Co stock (median: 24,480.00 KRW), implying +6.4 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the NeoPharm Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect NeoPharm Co to generate revenue of 171.50 B KRW and earnings per share of 2,013.01 KRW.
Converted at the current exchange rate, the NeoPharm Co share trades at 15.30 EUR (23,000.00 KRW).
The NeoPharm Co share (092730.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (092730.KQ).
The expected revenue of NeoPharm Co is 171.50 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of NeoPharm Co is 31.49 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of NeoPharm Co is currently 11.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the NeoPharm Co stock.
The price-to-sales ratio (P/S) of NeoPharm Co is currently 2.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the NeoPharm Co stock.
The Eulerpool Quality Score for NeoPharm Co is 8/10.
The ISIN of NeoPharm Co is KR7092730001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of NeoPharm Co is 092730.KQ. The ticker symbol is used to trade NeoPharm Co shares on the stock exchange.
NeoPharm Co stock
NeoPharm Co Peer Group
NeoPharm Co Ticker
NeoPharm Co FIGI
All fundamentals and in-depth analysis of NeoPharm Co
Our stock analysis for NeoPharm Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NeoPharm Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.